TMC 125 Blood Levels Study

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2007

Study Completion Date

December 31, 2007

Conditions
HIV Infections
Interventions
DRUG

TMC125 once daily

Group 1 (n =12): subjects will receive TMC125 400 mg once daily for 14 days followed by 14 days of washout followed by efavirenz 600 mg once daily for 14 days followed by 14 days of TMC125 400 mg once daily

DRUG

TMC125 twice daily

Group 2 (n = 12): TMC125 200 mg twice daily for 14 days followed by 14 days of washout followed by efavirenz 600 mg once daily for 14 days followed by 14 days of TMC125 200 mg twice daily

Trial Locations (1)

SW10 9th

St Stephens Centre, Chelsea & Westminster Hospital, London

All Listed Sponsors
lead

St Stephens Aids Trust

OTHER

NCT00531323 - TMC 125 Blood Levels Study | Biotech Hunter | Biotech Hunter